274 related articles for article (PubMed ID: 3157745)
1. In vivo treatment of neonatal mice with anti-I-A antibodies interferes with the development of the class I, class II, and Mls-reactive proliferating T cell subset.
Kruisbeek AM; Bridges S; Carmen J; Longo DL; Mond JJ
J Immunol; 1985 Jun; 134(6):3597-604. PubMed ID: 3157745
[TBL] [Abstract][Full Text] [Related]
2. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
[TBL] [Abstract][Full Text] [Related]
3. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
[TBL] [Abstract][Full Text] [Related]
4. The immunobiology of T cell responses to Mls-locus-disparate stimulator cells. II. Effects of Mls-locus-disparate stimulator cells on cloned, protein antigen-specific, Ia-restricted T cell lines.
Katz ME; Janeway CA
J Immunol; 1985 Apr; 134(4):2064-70. PubMed ID: 2579126
[TBL] [Abstract][Full Text] [Related]
5. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
6. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
Aberer W; Kruisbeek AM; Shimada S; Katz SI
J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
[TBL] [Abstract][Full Text] [Related]
7. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
Milich DR; Louie RE; Chisari FV
J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
[TBL] [Abstract][Full Text] [Related]
8. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
[TBL] [Abstract][Full Text] [Related]
9. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
Singer A; Kruisbeek AM; Andrysiak PM
J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
[TBL] [Abstract][Full Text] [Related]
10. In vivo functional clonal deletion of recipient CD4+ T helper precursor cells that can recognize class II MHC on injected donor lymphoid cells.
Kiziroglu F; Miller RG
J Immunol; 1991 Feb; 146(4):1104-12. PubMed ID: 1671401
[TBL] [Abstract][Full Text] [Related]
11. The immunobiology of the T cell response to Mls-locus-disparate stimulator cells. I. Unidirectionality, new strain combinations, and the role of Ia antigens.
Janeway CA; Katz ME
J Immunol; 1985 Apr; 134(4):2057-63. PubMed ID: 2579125
[TBL] [Abstract][Full Text] [Related]
12. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
Williams IR; Perry LL
J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
[TBL] [Abstract][Full Text] [Related]
14. Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells.
Powell TJ; Streilein JW
J Immunol; 1990 Feb; 144(3):854-9. PubMed ID: 2136901
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to class II major histocompatibility complex molecules is maintained in the presence of endogenous, interleukin-2-producing, tolerogen-specific T lymphocytes.
Mohler KM; Streilein JW
J Immunol; 1987 Oct; 139(7):2211-9. PubMed ID: 2958541
[TBL] [Abstract][Full Text] [Related]
16. Ia-positive nonlymphoid cells and T cell development in murine fetal thymus organ cultures: monoclonal anti-Ia antibodies inhibit the development of T cells.
DeLuca D
J Immunol; 1986 Jan; 136(2):430-9. PubMed ID: 2934471
[TBL] [Abstract][Full Text] [Related]
17. Sodium periodate-induced T cell mitogenesis: an analysis of the requirement for Ia and IL 1.
Smith LA; Cohen DA; Lachman LB; Kaplan AM
J Immunol; 1985 Aug; 135(2):1137-44. PubMed ID: 2989361
[TBL] [Abstract][Full Text] [Related]
18. The role of Ia molecules in the activation of T lymphocytes. II. Ia-restricted recognition of allo K/D antigens is required for class I MHC-stimulated mixed lymphocyte responses.
Rock KL; Barnes MC; Germain RN; Benacerraf B
J Immunol; 1983 Jan; 130(1):457-62. PubMed ID: 6600193
[TBL] [Abstract][Full Text] [Related]
19. Alteration of the T cell self-specificity repertoire by treatment with anti-Ia antibody during embryonic life.
Kimoto M; Kishimoto S
Eur J Immunol; 1986 Jul; 16(7):835-9. PubMed ID: 2941310
[TBL] [Abstract][Full Text] [Related]
20. In vivo IL-4 responses to anti-IgD antibody are MHC class II dependent and beta 2-microglobulin independent and develop normally in the absence of IL-4 priming of T cells.
Morris SC; Coffman RL; Finkelman FD
J Immunol; 1998 Apr; 160(7):3299-304. PubMed ID: 9531287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
